BNP Paribas Financial Markets’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $5.45M | Sell |
|
|||||
|
2025
Q2 | $4.27M | Buy |
|
|||||
|
2025
Q1 | $2.64M | Sell |
|
|||||
|
2024
Q4 | $2.88M | Buy |
|
|||||
|
2024
Q3 | $2.46M | Buy |
|
|||||
|
2024
Q2 | $1.37M | Buy |
|
|||||
|
2024
Q1 | $300K | Buy |
|
|||||
|
2023
Q4 | $288K | Buy |
|
|||||
|
2023
Q3 | $119K | Sell |
|
|||||
|
2023
Q2 | $169K | Sell |
|
|||||
|
2023
Q1 | $208K | Sell |
|
|||||
|
2022
Q4 | $489K | Buy |
|
|||||
|
2022
Q3 | $162K | Sell |
|
|||||
|
2022
Q2 | $984K | Sell |
|
|||||
|
2022
Q1 | $1.19M | Buy |
|
|||||
|
2021
Q4 | $848K | Buy |
|
|||||
|
2021
Q3 | $79.8K | Buy |
|
|||||
|
2021
Q2 | $30.1K | Sell |
|
|||||
|
2021
Q1 | $143K | Sell |
|
|||||
|
2020
Q4 | $173K | Sell |
|
|||||
|
2020
Q3 | $163K | Buy |
|
|||||
|
2020
Q2 | $64K | Sell |
|
|||||
|
2020
Q1 | $368K | Buy |
|
|||||
|
2019
Q4 | $159K | Sell |
|
|||||
|
2019
Q3 | $153K | Buy |
|
|||||
|
2019
Q2 | $94.6K | Sell |
|
|||||
|
2019
Q1 | $226K | Buy |
|
|||||
|
2018
Q4 | $25.9K | Sell |
|
|||||
|
2018
Q3 | $77.7K | Buy |
|
|||||
|
2018
Q2 | $49.8K | Sell |
|
|||||
|
2018
Q1 | $220K | Buy |
|
|||||
|
2017
Q4 | $242K | Buy |
|
|||||
|
2017
Q3 | $167K | Sell |
|
|||||
|
2017
Q2 | $205K | Buy |
|
|||||
|
2017
Q1 | $28.3K | Sell |
|
|||||
|
2016
Q4 | $85.9K | Sell |
|
|||||
|
2016
Q3 | $109K | Buy |
|
|||||
|
2016
Q2 | $32.5K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $102K | Buy |
|
|||||
|
2015
Q3 | $57.4K | Buy |
|
|||||
|
2015
Q2 | $29.7K | Buy |
|
|||||
|
2015
Q1 | $9.72K | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $32.4K | Buy |
|